Um eine neue Plattform zur Impfstoff-Produktion für einkommensschwache Länder zu entwickeln, untersuchte die vorliegende Studie die Herstellung transplastomer Pflanzen zur Expression von Antigenen gegen zwei Pathogene: Human Papilloma Virus (HPV) und Mycobacterium spp. Ein modifiziertes HPV L1 Gen mit GST als Fusionsprotein wurde in Tabak-Plastiden transformiert. Die Expression dieses rekombinanten Proteins wurde mittels Antigen Capture ELISA gezeigt, indem konformationsspezifische Antikörper am GST-L1 Fusionsprotein binden. Dieser Assay bestätigte dessen korrektes Assembly, die Voraussetzung einer positiven Immunreaktion. In einer Southern Blot Analyse wurde untersucht, ob die Pflanzen komplett transformiert sind. Dieser Test bestätigte di...
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great ...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Vielfältige Typen des Humanen Papillomavirus (HPV) verursachen Gebärmutterhals-krebs, den zweithäufi...
Transgene Pflanzen nehmen einen wachsenden Stellenwert bei der Produktion therapeutischer Proteine, ...
Mucosal vaccines created on the base of transgenic plants reacting with mucosal layers of the intest...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Durante este trabajo se obtuvieron distintas líneas de plantas de tabaco transplantómicas para el an...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Cervical cancer linked to infection with human papillomavirus (HPV) is the third cause of cancer-rel...
Since the development of methodologies for achieving genetic modification of chloroplast genomes, te...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great ...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Vielfältige Typen des Humanen Papillomavirus (HPV) verursachen Gebärmutterhals-krebs, den zweithäufi...
Transgene Pflanzen nehmen einen wachsenden Stellenwert bei der Produktion therapeutischer Proteine, ...
Mucosal vaccines created on the base of transgenic plants reacting with mucosal layers of the intest...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Durante este trabajo se obtuvieron distintas líneas de plantas de tabaco transplantómicas para el an...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Cervical cancer linked to infection with human papillomavirus (HPV) is the third cause of cancer-rel...
Since the development of methodologies for achieving genetic modification of chloroplast genomes, te...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great ...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...